Published in Liver Transpl on July 26, 2013
Early post-transplant survival: Interaction of MELD score and hospitalization status. J Hepatol (2015) 2.06
Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology (2014) 1.12
Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clin Infect Dis (2015) 0.90
Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience. HPB (Oxford) (2015) 0.82
The prediction accuracy of dynamic mixed-effects models in clustered data. BioData Min (2016) 0.76
The Impact of the Share 35 Policy on Racial and Ethnic Disparities in Access to Liver Transplantation for Patients with End Stage Liver Disease in the United States: An Analysis from UNOS Database. Int J Equity Health (2017) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl (2006) 2.62
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology (2008) 1.95
Geographic disparities in deceased donor liver transplantation within a single UNOS region. Liver Transpl (2007) 1.81
Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume. Ann Intern Med (2007) 1.81
Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant (2009) 1.47
Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant (2009) 1.34
Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl (2008) 1.30
D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant (2008) 1.27
Donor race does not predict graft failure after liver transplantation. Gastroenterology (2010) 1.03
Center competition and outcomes following liver transplantation. Liver Transpl (2013) 1.01
Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant (2006) 1.00
Accountability in health care--transplant community offers leadership. Am J Transplant (2009) 0.95
Relationship between provider volume and outcomes for orthotopic liver transplantation. J Gastrointest Surg (2008) 0.92
The impact of consecutive operations on survival after liver transplantation. Liver Transpl (2009) 0.92
Transplant center volume and outcomes after liver retransplantation. Am J Transplant (2008) 0.91
Race and receipt of liver transplantation: location matters. Liver Transpl (2010) 0.88
Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc (2003) 9.96
A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med (2002) 8.63
Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med (2007) 6.07
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet (2010) 4.75
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood (2005) 4.48
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl (2005) 4.46
POEMS syndrome: definitions and long-term outcome. Blood (2002) 4.35
Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum (2010) 3.84
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol (2004) 3.43
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology (2003) 3.22
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood (2004) 2.97
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood (2007) 2.87
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol (2011) 2.74
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood (2003) 2.68
Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63
Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc (2004) 2.62
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Serum aminotransferase activity and mortality risk in a United States community. Hepatology (2008) 2.61
Survival differences following lung transplantation among US transplant centers. JAMA (2010) 2.57
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis (2010) 2.54
Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology (2012) 2.44
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation (2007) 2.43
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc (2004) 2.43
Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology (2007) 2.36
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology (2012) 2.33
Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics (2004) 2.31
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer (2004) 2.31
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer (2014) 2.26
The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum (2007) 2.25
Sudden death after myocardial infarction. JAMA (2008) 2.24
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma. Am J Respir Crit Care Med (2014) 2.15
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum (2008) 2.14
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis (2008) 2.12
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res (2008) 2.07
The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med (2010) 2.06
Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: a multicenter randomized, double-blind trial. Ann Intern Med (2010) 2.05
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology (2013) 2.03
Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol (2008) 2.02
Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc (2007) 2.01
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis (2011) 2.01
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology (2011) 1.99
Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood (2006) 1.98
MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl (2007) 1.94
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum (2008) 1.94
Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology (2006) 1.93
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood (2009) 1.90
Autoantibodies and the risk of cardiovascular events. J Rheumatol (2009) 1.89
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc (2009) 1.88
Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant (2004) 1.87
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl (2007) 1.86
Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics (2011) 1.84
The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol (2011) 1.82
Pretransplantation disease severity and posttransplantation outcome. Liver Transpl (2003) 1.77
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology (2014) 1.75
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis (2008) 1.73
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology (2012) 1.70
Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation (2006) 1.69
Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol (2012) 1.69
Diagnosis of aortic valvular stenosis by multislice cardiac computed tomography. Eur Heart J (2006) 1.68
Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2007) 1.67
Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res (2008) 1.67
Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol (2010) 1.67
A statistical model for iTRAQ data analysis. J Proteome Res (2008) 1.67
A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol (2004) 1.66
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol (2004) 1.65
Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology (2003) 1.65
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet (2003) 1.64
Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62